re: Ozempic maker Novo Nordisk surges past Tesla with market value of $566B

quote:

---

well the plan of telling people to just eat less and move more has too and its not because it isnt the correct advice it is but it falls on deaf ears

---

I agree...the issue is patient non compliance. The burden of healthcare needs to shift more back to the patient. So, if a patient wants the medicine they can pay for it.

The mentality of I won't do ___ but I want ____ because I am not doing _____ but expecting someone else to pay for it is insanity.

Imagine how frequent Z91.1x would be coded if non compliance was a suitable diagnoses to treat non compliance pharmaceutically.